Price Comparison

PNC-27

research

3 vendors competing

3 of 3 vendors
Prices for PNC-27 by vendor
VendorPrice10mg costUpdatedActions
Atomik Labz7/10
7/10
COA ✓Ships: US + CanadaPayment not verified
Verification & shipping
7/10
COA ✓Ships: US + CanadaPayment not verified
$82.50$110.00−25% · code peptideprices10mg package$82.50Checked aug 4, 2026Aug 4, 2026Buy PNC-27 from Atomik Labz
Nationwide Peptides6/10
6/10
COA ✓Ships: USCredit/debit card
Verification & shipping
6/10
COA ✓Ships: USCredit/debit card
$162.00$180.00−10% · code peptideprices10mg package$162.00Checked aug 5, 2026Aug 5, 2026Buy PNC-27 from Nationwide Peptides
BioLongevity Labs8/10
8/10
COA ✓Ships: USCredit/debit card
Verification & shipping
8/10
COA ✓Ships: USCredit/debit card
$251.97$279.97−10% · code PEPTIDEPRICES10mg package$251.97Checked aug 2, 2026Aug 2, 2026Buy PNC-27 from BioLongevity Labs

Research details

PNC-27 — research data

Half-lifeNot established in humans.
Regulatory statusNot FDA-approved (FDA warning issued)
NCAA D1Not listed

Overview

About PNC-27

Mechanism of action

Synthetic peptide containing p53 activation domain fused to penetratin cell-penetrating sequence; selectively inserts into membranes of cancer cells (which overexpress HDM2); induces apoptosis in cancer cells while leaving normal cells unharmed.

Safety profile

Limited human data. Animal studies show selective cancer cell killing with minimal normal cell toxicity. Long-term safety profile not established. · ⚠️ FDA has explicitly warned against PNC-27 products; documented bacterial contamination (Variovorax paradoxus) in marketed material; ZERO verified human trials; marketed with unsubstantiated cancer-cure claims. Experimental only — never a usable cancer therapy.

Related pages

More on PNC-27

Research

Studies & key findings

  • ⚠️ PNC-27 is an unapproved experimental anticancer peptide that the FDA has explicitly warned against, with documented bacterial contamination in marketed products and NO verified human clinical trial data.
  • It is a 32-amino-acid chimeric peptide (a p53/HDM-2-binding domain fused to a membrane-penetrating sequence) studied in cell lines for selectively lysing cancer cells via membrane HDM-2.

3 peer-reviewed sources cited — clinical, preclinical, and regulatory.

Read full research →
Failed to fetch